4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-306110
Chief Operating Officer sold 4,351 shares at $23.38 ($101,730)
- Chief Operating Officer acquired 4,351 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Champoux Jennifer · Chief Operating Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +4,351 | $3.98 | $17,317 | 66,722 | D |
| 2026-07-15 | Sale : show line 2 in the form 10b5-1 | −4,351 | $23.38 | $101,730 | 62,371 | D |
| Open-market sales · 4,351 sh · avg $23.38 · $101,730 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-15 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −4,351 | 26,947 | D |
Loading xslF345X06/ownership.xml…